Patents by Inventor David Curtis Frantz

David Curtis Frantz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150141367
    Abstract: A prebiotic formulation for oral administration to a human comprising 2?-fucosyllactose, 3?-sialyllactose and 6?-sialyllactose, and a method for modulating or stimulating the growth of Bifidobacteria in the gut. The formulation may be an infant formula.
    Type: Application
    Filed: January 26, 2015
    Publication date: May 21, 2015
    Inventor: David Curtis Frantz
  • Publication number: 20140371173
    Abstract: A prebiotic formulation for oral administration to a human comprising 2?-fucosyllactose, 3?-sialyllactose and 6?-sialyllactose, and a method for modulating or stimulating the growth of Bifidobacteria in the gut. The formulation may be an infant formula.
    Type: Application
    Filed: February 3, 2012
    Publication date: December 18, 2014
    Applicant: NESTEC S.A.
    Inventor: David Curtis Frantz
  • Publication number: 20120208782
    Abstract: A prebiotic formulation for oral administration to a human comprising 2?-fucosyllactose, 3?-sialyllactose and 6?-sialyllactose, and a method for modulating or stimulating the growth of Bifidobacteria in the gut. The formulation may be an infant formula.
    Type: Application
    Filed: February 9, 2012
    Publication date: August 16, 2012
    Applicant: Wyeth LLC
    Inventor: David Curtis Frantz